[http://www.lmsoft.com/] GlcA beta(1-4) GlcNAc alpha(1-4) GlcA beta(1-4) GlcNAc C28H22N2Na2O23 Mol. Wt.: 820.6
Custom Synthesis - Sussex welcomes custom synthesis (di-, tri, tetra- or larger saccharide or glycosylamino glycan (GAG) oligosaccharide) and will utilise its synthetic expertise to accommodate the specific needs of our collaborative partners. For specific or custom requirements, please contact us at your convenience.
GlcA beta(1-4) GlcNAc C14H22NNaO12 Mol. Wt.: 419.31
GlcA beta(1-4) GlcNAc, 6S C14H21NNa2O15 Mol. Wt.: 521.36
Oligosaccharide & Glycosylaminoglycan Synthetic Solutions
Synthetic Heparin Disaccharides Produced by chemical synthesis from monosaccharide starting materials. Thus, no C4-C5 double bond artifact normally found in isolated heparin fragments.
GlcA beta(1-4) GlcNAc,6S alpha(1-4) GlcA beta(1-4) GlcNAc,6S C28H40N2Na4O29S2 Mol. Wt.: 1024.7
GlcA beta(1-4) GlcNAc alpha(1-4) GlcA beta(1-4) GlcNAc,6S C28H41N2Na3O26 Mol. Wt.: 922.7
GlcA beta(1-4) GlcNAc,6S alpha(1-4) GlcA beta(1-4) GlcNAc C28H41N2Na3O26 Mol. Wt.: 922.7
Other Synthetic Oligosaccharides
Alpha-D-galactopyranosyl-[1,1]-alpha-D-galactopyranoside - A galactose derivative of trehalose
Alpha-D-galactopyranosyl-[1,1]-beta-D-galactopyranoside - An alpha,beta galactose derivative of trehalose
Chitobiose octaacetate
Chitotriose peracetate
Sussex Research
Discover the therapeutic potential of carbohydrates
[./bluepag.html]
[./contactpag.html]
[./companypag.html]
[./sussex_newspag.html]
[./productspag.html]
[./servicespag.html]
[./technologypag.html]
[./site_mappag.html]
Site Map